Click Here for 5% Off Your First Aladdin Purchase!

exarafenib - ≥98%, high purity , CAS No.2639957-39-2, Inhibitor of Raf-1 proto-oncogene; serine/threonine kinase

  • Moligand™
  • ≥98%
Item Number
E610261
Grouped product items
SKUSizeAvailabilityPrice Qty
E610261-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$238.90
E610261-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$319.90
E610261-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$563.90
E610261-50mg
50mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$839.90
E610261-100mg
100mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,160.90

Basic Description

SynonymsExarafenib|Exarafenib [INN]|KIN-2787 free base|2VPX8HL8AB|2639957-39-2|UNII-2VPX8HL8AB|(3S)-N-(3-(2-(((2R)-1-Hydroxypropan-2-yl)amino)-6- (morpholin-4-yl)pyridin-4-yl)-4-methylphenyl)-3-(2,2,2- trifluoroethyl)pyrrolidine-1-carboxamide|1-Pyrrolidinecarboxa
Specifications & Purity≥98%
Storage TempProtected from light,Store at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionInhibitor of Raf-1 proto-oncogene; serine/threonine kinase
Product Description

Exarafenib (RAF/KIN_2787) is an orally-available, selective pan-RAF inhibitor. Exarafenib is effective in RAF-dependent cancers, including all classes of BRAF alterations. Exarafenib suppresses MAPK signaling in RAF-dependent melanoma cell lines. Exarafenib has anticancer activity.

Associated Targets

RAF1 Tclin RAF proto-oncogene serine/threonine-protein kinase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name (3S)-N-[3-[2-[[(2R)-1-hydroxypropan-2-yl]amino]-6-morpholin-4-ylpyridin-4-yl]-4-methylphenyl]-3-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide
INCHI InChI=1S/C26H34F3N5O3/c1-17-3-4-21(31-25(36)34-6-5-19(15-34)14-26(27,28)29)13-22(17)20-11-23(30-18(2)16-35)32-24(12-20)33-7-9-37-10-8-33/h3-4,11-13,18-19,35H,5-10,14-16H2,1-2H3,(H,30,32)(H,31,36)/t18-,19+/m1/s1
InChi Key GZMYLSJUNSCMTD-MOPGFXCFSA-N
Canonical SMILES Cc1c(cc(cc1)NC(=O)N1CC[C@H](C1)CC(F)(F)F)c1cc(nc(c1)N1CCOCC1)N[C@H](C)CO
Isomeric SMILES CC1=C(C=C(C=C1)NC(=O)N2CC[C@H](C2)CC(F)(F)F)C3=CC(=NC(=C3)N4CCOCC4)N[C@H](C)CO
PubChem CID 156297592
Molecular Weight 521.58

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Chemical and Physical Properties

SolubilityDMSO: 50 mg/mL (95.86 mM), Sonication is recommended.
SensitivityLight sensitive;Moisture sensitive

Related Documents

Solution Calculators